Sessions

PATIENT ENGAGEMENT: DRIVING PATIENT ADVOCACY TO INFORM PATIENT CENTRIC DEVELOPMENT
ATTRACTING & RETAINING TALENT TO DEVELOP THE WORKFORCE OF THE FUTURE
IMPROVING PATIENT EXPERIENCE WITHIN CLINICAL TRIALS & LONG TERM FOLLOW UP

PATIENT ENGAGEMENT: DRIVING PATIENT ADVOCACY TO INFORM PATIENT CENTRIC DEVELOPMENT

31 Aug 2022
11:00

11:00 – CHAIR INTRODUCTION

Chair: Karin Blumer, Director Global Patient Engagement, Novartis

 

11:05 – CASE STUDY: STRATEGIC APPROACH TO INTERNATIONAL HARMONISATION OF GENE THERAPY PRODUCTS

Speaker: Katherine Donigan, Senior Director Science & Regulatory, Biotechnology Innovation Organisation (BIO)

11:20 – CASE STUDY: THE TRUSTED BROKER: INVOLVING AND ENGAGING PATIENTS AND ADVOCATES IN POLICY MAKING 

Speaker: Anna Dickinson, Senior Policy Analyst Lifesciences, Public Policy Projects

 

11:35 – CASE STUDY: THE VALUE OF EARLY PATIENT ENGAGEMENT TO BUILD CREDIBILITY & SUPPORT FOR CLINICAL DEVELOPMENT OF A FIRST IN CLASS CELL THERAPY FOR HEARING LOSS

Speaker: Simon Chandler, CEO, Rinri Therapeutics

 

11:35 – CASE STUDY: PATIENT ENGAGEMENT AND CAR-T BUILDING A PLANE WHILST FLYING IT

Speaker: Karin Blumer, Director Global Patient Engagement, Novartis

 

12:05 – PANEL DISCUSSION 

Speakers:  

Anna Dickinson, Senior Policy Analyst Lifesciences, Public Policy Projects

Simon Chandler, CEO, Rinri Therapeutics

 

 

Speakers

Karin Blumer
Director Global Patient Engagement
Novartis
Anna Dickinson
Life Sciences - Policy Manager
Public Policy Projects